Literature DB >> 33213342

An Overview of Computer-aided Drug Design Tools and Recent Applications in Designing of Anti-diabetic Agents.

Paranjeet Kaur1, Gopal Khatik2.   

Abstract

BACKGROUND: In this fast-growing era, high throughput data is now being easily accessed by getting transformed into datasets which store the information. Such information is valuable to optimize the hypothesis and drug design via computer-aided drug design (CADD). Nowadays, we can explore the role of CADD in various disciplines like Nanotechnology, Biochemistry, Medical Sciences, Molecular Biology, etc.
Methods: We searched the valuable literature using a pertinent database with given keywords like computer-aided drug design, anti-diabetic, drug design, etc. We retrieved all valuable articles which are recent and discussing the role of computation in the designing of anti-diabetic agents.
RESULTS: To facilitate the drug discovery process, the computational approach has set landmarks in the whole pipeline for drug discovery from target identification and mechanism of action to the identification of leads and drug candidates. Along with this, there is a determined endeavor to describe the significance of in-silico studies in predicting the absorption, distribution, metabolism, excretion, and toxicity profile. Thus, globally, CADD is accepted with a variety of tools for studying QSAR, virtual screening, protein structure prediction, quantum chemistry, material design, physical and biological property prediction.
CONCLUSION: Computer-assisted tools are used as the drug discovery tool in the area of different diseases, and here we reviewed the collaborative aspects of information technologies and chemoinformatic tools in the discovery of anti-diabetic agents, keeping in view the growing importance for treating diabetes. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Antidiabetics; QSAR; chemoinfor-matic tools.; computer-aided drug design; molecular docking; virtual screening

Year:  2021        PMID: 33213342     DOI: 10.2174/1389450121666201119141525

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  2 in total

Review 1.  Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review).

Authors:  Mihaela Jana Tuculina; Paula Perlea; Mircea Gheorghiță; Cristian Niky Cumpătă; Ionela Teodora Dascălu; Adina Turcu; Andreea Gabriela Nicola; Lelia Mihaela Gheorghiță; Oana Andreea Diaconu; Ana Valea; Adina Ghemigian; Mara Carsote
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

2.  Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis.

Authors:  Rui Wang; Jian Xu; Rong Yan; Huanbin Liu; Jingxin Zhao; Yuan Xie; Wenbin Deng; Weiping Liao; Yichu Nie
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.